News
Gynecologic Cancer: Subtle Warning Signs That Are Often Dismissed
... Here goes the content ...
Latha Chandran leaves a lasting Miller School legacy through NextGenMD, faculty development and transformative medical education leadership. FDA approves daraxonrasib for metastatic pancreatic cancer after a phase 3 trial showed patients lived nearly twice as long as with chemotherapy. AI-tested visuals and cancer-specific messages may improve awareness of alcohol-related cancer risks, according to a Sylvester study. The Florida Stroke Registry has received a record $2 million state appropriation to strengthen stroke prevention efforts across Florida.
A Legacy of Transforming Medical Education: Dr. Latha Chandran Retires from the Miller School of Medicine

FDA Approval Opens New Chapter in Pancreatic Cancer Treatment

Can AI Improve Public Awareness of Alcohol-Related Cancer Risks?

Florida Stroke Registry Receives Record $2 Million State Funding to Improve Stroke Care






